Dr Elizabeth Hill of Cambridge Consultants appointed Biotechnology Advisor to New Zealand
2008-06-16 18:12:32 -
- Cambridge Consultants Patrick Pordage, Marketing and Communications Director Tel: +44 (0)1223 420024 Patrick.Pordage@CambridgeConsultants.com or European PR EML Katie Robertson Tel: +44 (0)208 408 8000 cambridgeconsultants@eml.com or USA PR Bridgeman Communications Geoff Buteau Tel: +1 617 742 7270 cambridgeconsultants@eml.com Cambridge Consultants today announced that Dr Elizabeth Hill, Head of Transaction Support, has been nominated European Biotechnology Advisor to New Zealand.
Dr Hill's role involves providing expert recommendations and opinions about the global Biotech market to New Zealand companies in the space. She is part of the Beachheads advisory board, which gives high-growth-potential companies faster access to better international networks. Beachheads provide input and expertise from industry luminaries to help New Zealand and offshore businesses accelerate their entry and growth in key export markets.
Dr Hill has over twenty years experience in the technology sector, focused mainly on healthcare and life sciences. She has held a number of directorships including the UK NHS Health Authority and is currently a member of an independent healthcare council.
Dr Hill commented, "New Zealand's research institutions, together with its wide range of domestic and international alliances, continue to play a critical role in the development of the Biotechnology sector. New Zealand also offers the valuable combination of IT expertise in healthcare together with a range of natural biological sources, making it an ideal partner for a range of life science and healthcare companies."
Dr Hill will be attending the BIO International Convention in San Diego from June 17th - 20th, 2008. She will meet a number of companies and also participate in a series of high-level meetings about the future of Biotech research and potential partnerships between companies in New Zealand and other markets.
Notes to Editors:
Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology critical issues for clients worldwide. For nearly 50 years, the company has enabled its clients to turn business opportunities into commercial successes, whether launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies.
With a team of over 250 engineers, designers, scientists and consultants, in offices in Cambridge (UK) and Boston (USA), Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, automotive, transport, energy and wireless communications. For more information visit: www.CambridgeConsultants.com
Cambridge Consultants is part of the Altran group of companies. Altran Technologie, which is listed on the Paris Stock Exchange (FR:003463), employs over 17,000 consultants in 20 countries around the world. In 2006 the group generated a turnover of EUR 1,495.6 million. For more information visit: www.altran.com
The digital image associated with this press release is available at: www.eml.com/images/cc031.jpg
ΒΆ -- Head of Transaction Support at Cambridge Consultants to
Counsel New Zealand Biotech Companies on Entry into New
Markets
